• One Biosciences, a biotech company that incorporates AI to help identify therapeutic targets, has received over $16M in a Series A round with participation from the Invus Group Family Office

Source Of Information: 

Disclaimer:

• All content provided by Let's Talk Family Office℠ is for informational and educational purposes only and should not be taken as legal or professional advice. The information contained in this content is not maintained or endorsed or guaranteed by Let's Talk Family Office℠ or it's associates. Always seek legal or professional advice from a professional.